D8 and D9-cadherin targeting monoclonal antibodies (ITM Radiopharmazie Munchen)

N/A

Report date: 2025/03/18 20:00:05

Base Information

Drug NameD8 and D9-cadherin targeting monoclonal antibodies (ITM Radiopharmazie Munchen)
Drug Alias Namedelta 8 and delta 9-cadherin targeting monoclonal antibodies (Helmholtz Zentrum München)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionCadherin-1 modulators
TargetsCadherin-1
Therapy Area/IndicationsStomach Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesHelmholtz Zentrum Muenchen
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesITM Radiopharmazie Munchen GmbH
Active IndicationsN/A
Inactive IndicationsStomach Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A